414 related articles for article (PubMed ID: 21164021)
1. The regulation of parathyroid hormone secretion and synthesis.
Kumar R; Thompson JR
J Am Soc Nephrol; 2011 Feb; 22(2):216-24. PubMed ID: 21164021
[TBL] [Abstract][Full Text] [Related]
2. Cellular and molecular mechanisms of secondary hyperparathyroidism.
Silver J; Levi R
Clin Nephrol; 2005 Feb; 63(2):119-26. PubMed ID: 15730054
[TBL] [Abstract][Full Text] [Related]
3. Roles of calcium-sensing receptor and vitamin d receptor in the pathophysiology of secondary hyperparathyroidism.
McCann LM; Beto J
J Ren Nutr; 2010 May; 20(3):141-50. PubMed ID: 20303786
[TBL] [Abstract][Full Text] [Related]
4. Regulation of PTH synthesis and secretion relevant to the management of secondary hyperparathyroidism in chronic kidney disease.
Silver J; Levi R
Kidney Int Suppl; 2005 Jun; (95):S8-12. PubMed ID: 15882315
[TBL] [Abstract][Full Text] [Related]
5. Cinacalcet HCl: a novel treatment for secondary hyperparathyroidism caused by chronic kidney disease.
Torres PU
J Ren Nutr; 2006 Jul; 16(3):253-8. PubMed ID: 16825031
[TBL] [Abstract][Full Text] [Related]
6. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
7. Pathogenesis of secondary hyperparathyroidism.
Slatopolsky E; Brown A; Dusso A
Kidney Int Suppl; 1999 Dec; 73():S14-9. PubMed ID: 10633458
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of secondary hyperparathyroidism.
Silver J; Kilav R; Naveh-Many T
Am J Physiol Renal Physiol; 2002 Sep; 283(3):F367-76. PubMed ID: 12167586
[TBL] [Abstract][Full Text] [Related]
9. Regulation of PTH mRNA stability by the calcimimetic R568 and the phosphorus binder lanthanum carbonate in CKD.
Nechama M; Ben-Dov IZ; Silver J; Naveh-Many T
Am J Physiol Renal Physiol; 2009 Apr; 296(4):F795-800. PubMed ID: 19129257
[TBL] [Abstract][Full Text] [Related]
10. Regulation of parathyroid hormone synthesis in chronic renal failure in rats.
Fukagawa M; Kaname S; Igarashi T; Ogata E; Kurokawa K
Kidney Int; 1991 May; 39(5):874-81. PubMed ID: 2067203
[TBL] [Abstract][Full Text] [Related]
11. Pin1 regulates parathyroid hormone mRNA stability.
Kumar R
J Clin Invest; 2009 Oct; 119(10):2887-91. PubMed ID: 19770518
[TBL] [Abstract][Full Text] [Related]
12. The role of phosphorus in the development of secondary hyperparathyroidism and parathyroid cell proliferation in chronic renal failure.
Slatopolsky E; Dusso A; Brown AJ
Am J Med Sci; 1999 Jun; 317(6):370-6. PubMed ID: 10372836
[TBL] [Abstract][Full Text] [Related]
13. 25-Hydroxyvitamin D(3) suppresses PTH synthesis and secretion by bovine parathyroid cells.
Ritter CS; Armbrecht HJ; Slatopolsky E; Brown AJ
Kidney Int; 2006 Aug; 70(4):654-9. PubMed ID: 16807549
[TBL] [Abstract][Full Text] [Related]
14. The calcimimetic AMG 073 as a potential treatment for secondary hyperparathyroidism of end-stage renal disease.
Quarles LD; Sherrard DJ; Adler S; Rosansky SJ; McCary LC; Liu W; Turner SA; Bushinsky DA
J Am Soc Nephrol; 2003 Mar; 14(3):575-83. PubMed ID: 12595492
[TBL] [Abstract][Full Text] [Related]
15. Pathogenesis of parathyroid dysfunction in end-stage renal disease.
Silver J
Adv Ren Replace Ther; 2002 Jul; 9(3):159-67. PubMed ID: 12203197
[TBL] [Abstract][Full Text] [Related]
16. The peptidyl-prolyl isomerase Pin1 determines parathyroid hormone mRNA levels and stability in rat models of secondary hyperparathyroidism.
Nechama M; Uchida T; Mor Yosef-Levi I; Silver J; Naveh-Many T
J Clin Invest; 2009 Oct; 119(10):3102-14. PubMed ID: 19770516
[TBL] [Abstract][Full Text] [Related]
17. New insights into the regulation of parathyroid hormone synthesis and secretion in chronic renal failure.
Silver J; Moallem E; Kilav R; Epstein E; Sela A; Naveh-Many T
Nephrol Dial Transplant; 1996; 11 Suppl 3():2-5. PubMed ID: 8840303
[TBL] [Abstract][Full Text] [Related]
18. The calcimimetic AMG 073 reduces parathyroid hormone and calcium x phosphorus in secondary hyperparathyroidism.
Lindberg JS; Moe SM; Goodman WG; Coburn JW; Sprague SM; Liu W; Blaisdell PW; Brenner RM; Turner SA; Martin KJ
Kidney Int; 2003 Jan; 63(1):248-54. PubMed ID: 12472790
[TBL] [Abstract][Full Text] [Related]
19. Functional proteins involved in regulation of intracellular Ca(2+) for drug development: the extracellular calcium receptor and an innovative medical approach to control secondary hyperparathyroidism by calcimimetics.
Nagano N; Nemeth EF
J Pharmacol Sci; 2005 Mar; 97(3):355-60. PubMed ID: 15781990
[TBL] [Abstract][Full Text] [Related]
20. The molecular basis of secondary hyperparathyroidism in chronic renal failure.
Rahamimov R; Silver J
Isr J Med Sci; 1994 Jan; 30(1):26-31. PubMed ID: 8138394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
